Neuroblastoma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Neuroblastoma is the most common solid extracranial cancer in childhood and is the most common cancer in infancy. The overall incidence is 4.9 per 1,000,000 individuals in united states. Males are slightly more affected than females with 1.2:1 ratio. Neuroblastoma usually affects individuals of the caucasian race. | Neuroblastoma is the most common solid extracranial cancer in childhood and is the most common cancer in infancy. The overall incidence is 4.9 per 1,000,000 individuals in united states. Males are slightly more affected than females with 1.2:1 ratio. Neuroblastoma usually affects individuals of the caucasian race.<ref>{{Cite journal | ||
| author = [[Tadeusz Izbicki]], [[Joanna Mazur]] & [[Elzbieta Izbicka]] | |||
| title = Epidemiology of neuroblastoma: analysis of a single institution | |||
| journal = [[Anticancer research]] | |||
| volume = 23 | |||
| issue = 2C | |||
| pages = 1933–1938 | |||
| year = 2003 | |||
| month = March-April | |||
| pmid = 12820482 | |||
}}</ref> | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
Revision as of 14:27, 14 February 2019
|
Neuroblastoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Neuroblastoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Neuroblastoma epidemiology and demographics |
|
Risk calculators and risk factors for Neuroblastoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2] Zahir Ali Shaikh, MD[3]
Overview
Neuroblastoma is the most common solid extracranial cancer in childhood and is the most common cancer in infancy. The overall incidence is 4.9 per 1,000,000 individuals in united states. Males are slightly more affected than females with 1.2:1 ratio. Neuroblastoma usually affects individuals of the caucasian race.[1]
Epidemiology and Demographics
Prevalence
- Neuroblastoma is the most common extracranial solid cancer in childhood and the most common cancer in infancy.
Incidence
- The overall incidence rate of neuroblastoma is approximately 4.9 per 1,000,000 individuals in the United States.[2][3]
Age
- The incidence of neuroblastoma decreases with age; the highest incidence is in the first year of life.
- The incidence of neuroblastoma according to specific age groups is approximately:[2]
- 25.3 per 1,000,000 individuals aged between (0-4) years
- 2.3 per 1,000,000 individuals aged between (5-9) years
- 0.7 per 1,000,000 individuals aged between (10-14) years
- 0.2 per 1,000,000 individuals aged between (20-24) years
- 0.3 per 1,000,000 individuals aged between (25-29) years
Gender
- Males are slightly more commonly affected with neuroblastoma than females. The male to female ratio is approximately 1.12 to 1.
- The incidence rate of neuroblastoma among males is approximately 5.1 per 1,000,000 individuals in the United States.
- The incidence rate of neuroblastoma among females is approximately 4.6 per 1,000,000 individuals in the United States.[2]
Race
- Neuroblastoma usually affects individuals of the Caucasian race. African Americans, Native Indians, and Asians are less likely to develop neuroblastoma.
- The incidence rate of neuroblastoma among Caucasians is approximately 5.1 per 1,000,000 individuals in the United States.
- The incidence rate of neuroblastoma among African Americans is approximately 4.1 per 1,000,000 individuals in the United States.
- The overall incidence rate of neuroblastoma among Native Indians and Asians is approximately 3.8 per 1,000,000 individuals in the United States.[2]
References
- ↑ Tadeusz Izbicki, Joanna Mazur & Elzbieta Izbicka (2003). "Epidemiology of neuroblastoma: analysis of a single institution". Anticancer research. 23 (2C): 1933–1938. PMID 12820482. Unknown parameter
|month=ignored (help) - ↑ 2.0 2.1 2.2 2.3 Navalkele P, O'Dorisio MS, O'Dorisio TM, Zamba GK, Lynch CF (2011). "Incidence, survival, and prevalence of neuroendocrine tumors versus neuroblastoma in children and young adults: nine standard SEER registries, 1975-2006". Pediatr Blood Cancer. 56 (1): 50–7. doi:10.1002/pbc.22559. PMC 4251713. PMID 21108439.
- ↑ J. G. Gurney, J. A. Ross, D. A. Wall, W. A. Bleyer, R. K. Severson & L. L. Robison (1997). "Infant cancer in the U.S.: histology-specific incidence and trends, 1973 to 1992". Journal of pediatric hematology/oncology. 19 (5): 428–432. PMID 9329464. Unknown parameter
|month=ignored (help)